1. Home
  2. ARES vs BNTX Comparison

ARES vs BNTX Comparison

Compare ARES & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARES
  • BNTX
  • Stock Information
  • Founded
  • ARES 1997
  • BNTX 2008
  • Country
  • ARES United States
  • BNTX Germany
  • Employees
  • ARES N/A
  • BNTX N/A
  • Industry
  • ARES Investment Managers
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ARES Finance
  • BNTX Health Care
  • Exchange
  • ARES Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • ARES 35.1B
  • BNTX 23.9B
  • IPO Year
  • ARES 2014
  • BNTX 2019
  • Fundamental
  • Price
  • ARES $176.85
  • BNTX $114.70
  • Analyst Decision
  • ARES Buy
  • BNTX Strong Buy
  • Analyst Count
  • ARES 14
  • BNTX 14
  • Target Price
  • ARES $164.00
  • BNTX $141.60
  • AVG Volume (30 Days)
  • ARES 1.2M
  • BNTX 1.1M
  • Earning Date
  • ARES 11-01-2024
  • BNTX 11-04-2024
  • Dividend Yield
  • ARES 2.10%
  • BNTX N/A
  • EPS Growth
  • ARES 0.39
  • BNTX N/A
  • EPS
  • ARES 2.19
  • BNTX N/A
  • Revenue
  • ARES $3,679,765,000.00
  • BNTX $3,390,698,192.00
  • Revenue This Year
  • ARES $0.31
  • BNTX N/A
  • Revenue Next Year
  • ARES $33.19
  • BNTX N/A
  • P/E Ratio
  • ARES $80.96
  • BNTX N/A
  • Revenue Growth
  • ARES 4.67
  • BNTX N/A
  • 52 Week Low
  • ARES $107.69
  • BNTX $76.53
  • 52 Week High
  • ARES $180.38
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • ARES 60.16
  • BNTX 53.01
  • Support Level
  • ARES $173.83
  • BNTX $101.02
  • Resistance Level
  • ARES $178.22
  • BNTX $121.80
  • Average True Range (ATR)
  • ARES 3.45
  • BNTX 5.54
  • MACD
  • ARES 0.04
  • BNTX 0.94
  • Stochastic Oscillator
  • ARES 76.37
  • BNTX 74.17

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets and Secondaries Group. Its Credit Group generates maximum revenue, and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: